PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Hoth Therapeutics, Inc.
Filed: November 3, 2022
Period of Report: November 3, 2022
Accession Number: 0001213900-22-068990

View Document ↗ View on SEC.gov ↗